Lateral Flow Assays Market

Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, STI, Hepatitis, TB) Cardiac Marker Lipid Test) Veterinary, Food Safety), Product, Technique, End User - Global Forecast to 2025

Report Code: MD 4158 Nov, 2020, by marketsandmarkets.com

[346 Pages Report] The lateral flow assays market is projected to reach USD 10.2 billion by 2025 from USD 8.2 billion in 2020, at a CAGR of 4.5% during the forecast period. The high prevalence of infectious diseases globally, rapidly aging population, growing demand for point-of-care testing, and home-based lateral flow assay devices are the major factors driving the growth of this market.

Attractive Opportunities in the Lateral flow assays Market

To know about the assumptions considered for the study, Request for Free Sample Report

Covid-19 Impact on the Lateral flow assays Market

In the optimistic scenario, it could be assumed that the COVID-19 pandemic has created a highly positive impact on the overall lateral flow assays market. The lateral flow assays market has been positively impacted by the COVID-19 pandemic, as the need for rapid diagnosis of the coronavirus infection has been the focus since the inception of the pandemic outbreak in December 2019. As the number of cases have increased across regions, most of the major lateral flow assay market players have invested in R&D, as well as have entered into partnerships and agreements with other industry players and government agencies, to develop lateral flow diagnostic solutions for the disease. This has resulted in multiple product launches of COVID-19 antibody and antigen tests, with surplus production and distribution of these tests across regions to serve the rising demand. Although the diagnostic accuracy of these tests is lower than some other methods, their affordability, convenience, ease of use, and quick turnaround time have led to their high uptake and acceptance, especially for screening for data collection. 

Lateral flow assays Market Dynamics 

Driver: High prevalence of infectious diseases across the globe

Despite significant improvements in sanitation and medicine, the global prevalence of infectious diseases is still high. Although non-communicable diseases are the leading cause of morbidity and mortality, infectious diseases remain a major public health concern across the globe. According to the National Institute of Allergy and Infectious Diseases, annually, infectious diseases claim more than 15 million lives globally. This factor is a major driver for the growth of the lateral flow assays market in the forecast period. 

Restraint: Lower accuracy of lateral flow assay tests

Lateral flow assay tests, although easy to perform and more economical than laboratory tests, have been observed to have lower accuracy. For instance, the SARS-CoV-2 antibody tests, based on the lateral flow technology, have shown a large margin of error. This has led to false negatives, which make it difficult to track the spread of the coronavirus. According to Global Health Research and Innovation at Johns Hopkins Medicine, 10–25% of all test results are false negative. The low reliability of lateral flow assay tests has resulted in most clinicians and patients preferring molecular tests over rapid tests for the more accurate diagnosis of COVID-19. 

Opportunity:Evolving applications of lateral flow assays 

In the last two decades, lateral flow assays have evolved rapidly and are routinely being used in POC and diagnostic applications. Although lateral flow tests are widely being used for infectious disease diagnostics, the diagnosis of cardiac diseases, and veterinary applications, their use has increased in several new applications over the last few years. This broadening scope of applications of lateral flow assays poses an opportunity for the growth of the market over the forecast period. 

Challenge:Rising prices and poor availability of raw materials 

One of the major challenges facing the global lateral flow assays market is the limited reimbursements for lateral flow assay products. Owing to reimbursement issues, lateral flow assay-based diagnostic tests have witnessed limited adoption in several countries across the globe. The rise in healthcare expenditure is compelling insurance payers to question and analyze the necessity of new diagnostic tests. Also, payers are moving from fee-for-service reimbursement systems towards fee-for-value-based reimbursement systems. This is one of the challenges facing the lateral flow assays market in the forecast period. 

Thelateral flow readers segment is expected to grow at the highest CAGR in the lateral flow assays market, by product, in the forecast period 

Lateral flow readers enable the quantitative analysis of lateral flow strips in sandwich, competitive, and reverse-competitive test formats. Readers measure the intensity of the test line to determine the quantity of analytes in the sample and provide a fully quantitative assay result. Readers perform multiple readings from a single device or a single read for multiple devices, followed by automatic statistical analysis of the results to give a consolidated value. Moreover, lateral flow readers are highly sensitive and can quantify and accurately capture and transmit data. These factors promote the high growth of this segment in the forecast period 

The clinical testing segment is expected to dominate the lateral flow assay market by application through forecast period 

In 2019, the clinical testing segment accounted for the largest share of the lateral flow assays market by application in the forecast period. This segment is further categorized as pregnancy & fertility testing, infectious disease testing, cardiac marker testing, cholesterol testing/lipid profiles, drugs-of-abuse testing, and other tests. Clinical tests are used primarily to replace lab-based immunoassays with decentralized testing, generally known as point-of-care (POC) testing. Compared to centralized (lab) testing, POC testing provides much faster results; due to this, LFA-based POC devices are rapidly being adopted for qualitative and quantitative analysis. These factors are responsible for the growth of this segment in the forecast period. 

Sandwich Assays holds the highest share in the lateral flow assay kits & reagents market by technique segment 

In 2019, the sandwich assays segment accounted for the largest share of the lateral flow assay kits & reagents market by technique. The wide applications of these assays in clinical testing and the advantages associated with the use of these assays, such as higher sensitivity and specificity for larger analytes, are the major factors driving the growth of the sandwich assays market. 

Other Samples is expected to grow at the highest CAGR in the lateral flow assays, by sample segment  during the forecast period 

Based on sample type, the lateral flow assay market is segmented into blood samples, urine samples, saliva samples, and other samples. The other samples segment is expected to grow at the highest CAGR in the forecast period due to increase in R&D and the need for more specific and accurate disease testing. 

North America is expected to dominate the lateral flow assay market, by region, during the forecast period 

The lateral flow assays market in the US is expected to offer lucrative growth opportunities due to the presence of several large hospitals and health systems, changing regulations, and the rising geriatric population in the country. A vast majority of global players are also based in the US, owing to which, the country is a center for innovation in the lateral flow assays market. The current COVID-19 pandemic has further boosted investments in research and innovation in the lateral flow assays market in the region, through funding and support from government organizations. These factors are contributing to highest share of this region in the lateral flow assays market in the forecast period. 

Lateral Flow Assays Market By Region

To know about the assumptions considered for the study, download the pdf brochure

Key players in the lateral flow assays market: 

The prominent players in the global lateral flow assays market includeAbbott Laboratories (US), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (US), Siemens AG (Germany), Becton, Dickinson and Company (US), bioMérieux SA (France), Bio-Rad Laboratories (US), Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Quidel Corporation (US), Merck KGaA (Germany), Abcam plc (UK), Surmodics IVD (US), Chembio Diagnostic Systems, Inc. (US), OraSure Technologies (US), DCN Diagnostics (US), Polysciences, Inc. (US), Abingdon Health (UK), BioPorto Diagnostics A/S (Denmark), Microcoat Biotechnologie GmbH (Germany), Scienion AG (Germany), Senova GmbH (Germany), and Access Bio, Inc. (US). 

Scope of the Report:

Report Metric

Details

Market Size available for years

2018-2025

Base Year Considered

2019

Forecast period

2020-2025

Forecast Unit

Value(USD Billion)

Segments covered

Product, Application, Sample,

Geographies covered

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Rest of Europe(RoE)

Asia Pacific
China
Japan
India
Australia
Rest of Asia Pacific (RoAPAC)
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa

Companies Covered

Abbott Laboratories (US), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (US), Siemens AG (Germany), Becton, Dickinson and Company (US), bioMérieux SA (France), Bio-Rad Laboratories (US), Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Quidel Corporation (US), Merck KGaA (Germany), Abcam plc (UK), Surmodics IVD (US), Chembio Diagnostic Systems, Inc. (US), OraSure Technologies (US), DCN Diagnostics (US), Polysciences, Inc. (US), Abingdon Health (UK), BioPorto Diagnostics A/S (Denmark), Microcoat Biotechnologie GmbH (Germany), Scienion AG (Germany), Senova GmbH (Germany), and Access Bio, Inc. (US).

The research report categorizes the market into the following segments and subsegments:

Lateral Flow Assays Market, By Product

  • Kits & Reagents
  • Lateral Flow Readers
    • Digital/Handheld Readers
    • Benchtop Readers
    • Mobile/Smartphone Readers

Lateral Flow Assays Market, By Application

  • Clinical Testing
    • Infectious Disease Testing
      • Mosquito-borne Diseases
      • Covid-19
      • Influenza
      • Sexually Transmitted Infections
        • HIV
        • HPV
        • Chlamydia
        • Gonorrhea
        • Syphilis
        • Other Sexually Transmitted Infections
      • Hepatitis
      • Tuberculosis
      • Other Infectious Diseases
    • Cardiac Marker Testing
      • Troponin I and T Testing
      • CK-MB Testing
      • BNP or NT-proBNP Testing
      • Myoglobin Testing
      • D-Dimer Testing
      • Other Cardiac Markers
    • Pregnancy & Fertility Testing
      • Pregnancy Testing
      • Fertility Testing
    • Cholesterol Testing/Lipid Profiles
    • Drugs-of-Abuse Testing
  • Veterinary Diagnostics
  • Food Safety & Environment Testing
  • Drug Development & Quality Testing

Lateral Flow Assay Kits & Reagents Market, by Technique

  • Sandwich Assays
  • Competitive Assays
  • Multiplex Detection Assays 

Lateral Flow Assays Market, by Sample Type 

  • Blood Samples
  • Urine Samples
  • Saliva Samples
  • Other Samples 

Lateral Flow Assays Market, by End User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Pharmaceutical & Biotechnology Companies
  • Other End Users 

Lateral Flow Assays Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa 

Recent Developments 

  • In September 2020, Abbott Laboratories (US) launched the PanBio COVID-19 immunochromatographic test for rapid qualitative detection of Sars-CoV-2 virus in Europe.
  • In September 2020, F.Hoffman La Roche Ltd. (Switzerland) launched the SARS CoV-2 Rapid Antigen Test in markets accepting the CE Mark.
  • In September 2020, Thermofisher Scientific, Inc. (US)opened a new Bioprocessing Collaboration Center (BCC) in Missouri, US, to bring together its expertise in GMP biologics manufacturing and bioprocessing technologies, including chromatography and analytical tools.
  • In September 2020, Qiagen N.V. (Netherlands) acquired NeuMoDx Molecular, Inc. (US), with the acquisition helping to broaden QIAGEN’s diagnostic instrument product portfolio.
  • In September 2020, Siemens Healthineers (Germany) collaborated with US Centers for Disease Control and Prevention (CDC) & Joint Research Center (JRC) of European Commission on a research project which helped Siemens Healthineers develop novel processes for standardizing SARS-CoV2 assays.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 44)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS IN THE LATERAL FLOW ASSAYS MARKET
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
           1.4.1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 49)
    2.1 RESEARCH APPROACH
           2.1.1 RESEARCH DESIGN
           2.1.2 SECONDARY DATA
                    2.1.2.1 Key data from secondary sources
           2.1.3 PRIMARY DATA
                    2.1.3.1 Primary sources
                    2.1.3.2 Key data from primary sources
                    2.1.3.3 Breakdown of primaries
       FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
 FIGURE 2 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2019)
 FIGURE 3 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2019)
 FIGURE 4 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAYS MARKET (2019)
 FIGURE 5 APPROACH 3: DEMAND-SIDE APPROACH, BASED ON THE MALARIA LATERAL FLOW TESTING MARKET SIZE (2019)
 FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE LATERAL FLOW ASSAYS MARKET (2019)
 FIGURE 7 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE LATERAL FLOW ASSAYS MARKET (2020-2025)
    2.3 MARKET BREAKDOWN & DATA TRIANGULATION
 FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ESTIMATION
    2.5 ASSUMPTIONS FOR THE STUDY
    2.6 COVID-19 HEALTH ASSESSMENT
    2.7 COVID-19 ECONOMIC ASSESSMENT
    2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
 FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY
    2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAYS MARKET

3 EXECUTIVE SUMMARY (Page No. - 64)
  FIGURE 11 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
  FIGURE 12 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2020 VS. 2025 (USD MILLION)
  FIGURE 13 LATERAL FLOW ASSAYS MARKET, BY APPLICATION,  2020 VS. 2025 (USD MILLION) 65
  FIGURE 14 CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2020 VS. 2025 (USD MILLION)
  FIGURE 15 LATERAL FLOW ASSAYS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
  FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAYS MARKET

4 PREMIUM INSIGHTS (Page No. - 69)
    4.1 LATERAL FLOW ASSAYS MARKET OVERVIEW
 FIGURE 17 RISING COVID-19 PATIENT POPULATION AND GROWTH IN THE PREVALENCE OF INFECTIOUS DISEASES IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAYS MARKET
    4.2 REGIONAL MIX: LATERAL FLOW ASSAYS MARKET
 FIGURE 18 APAC TO REGISTER THE HIGHEST CAGR OF 7.0% DURING THE FORECAST PERIOD
    4.3 LATERAL FLOW ASSAYS MARKET: DEVELOPED VS. DEVELOPING MARKETS
 FIGURE 19 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 71)
    5.1 INTRODUCTION
 FIGURE 20 LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,  AND CHALLENGES
    5.2 MARKET DYNAMICS: IMPACT ANALYSIS
           5.2.1 MARKET DRIVERS
                    5.2.1.1 High prevalence of infectious diseases across the globe
       FIGURE 21 PREVALENCE OF INFECTIOUS DISEASES WORLDWIDE
       TABLE 1 PREVALENCE OF HIV WORLDWIDE (2017 VS. 2019)
                    5.2.1.2 Rapidly increasing geriatric population
       FIGURE 22 GERIATRIC POPULATION, BY REGION, 2019 VS. 2030 (MILLION)
       FIGURE 23 GERIATRIC POPULATION, BY COUNTRY, 2010 VS. 2019 (MILLION)
                    5.2.1.3 Growing usage of home-based lateral flow assay devices
                    5.2.1.4 Growing demand for point-of-care testing
                    5.2.1.5 Need for rapid diagnostic testing for COVID-19
       FIGURE 24 NUMBER OF CONFIRMED CASES OF COVID-19, BY WHO REGION (MILLION)
           5.2.2 MARKET RESTRAINTS
                    5.2.2.1 Reluctance towards changing existing diagnostic practices
                    5.2.2.2 Lower accuracy of lateral flow assay tests
           5.2.3 MARKET OPPORTUNITIES
                    5.2.3.1 Evolving applications of lateral flow assays
       TABLE 2 LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS
                    5.2.3.2 Rising demand for lateral flow assays in the food & beverage industry
           5.2.4 CHALLENGES
                    5.2.4.1 Limited reimbursements for lateral flow assay products
                    5.2.4.2 Difficulties in procuring quality raw materials for the development of lateral flow assay tests
    5.3 PORTER'S FIVE FORCES ANALYSIS
 TABLE 3 LATERAL FLOW ASSAYS MARKET: PORTER'S FIVE FORCES ANALYSIS
           5.3.1 THREAT FROM NEW ENTRANTS
           5.3.2 THREAT FROM SUBSTITUTES
           5.3.3 BARGAINING POWER OF SUPPLIERS
           5.3.4 BARGAINING POWER OF BUYERS
           5.3.5 INTENSITY OF COMPETITIVE RIVALRY
    5.4 AVERAGE SELLING PRICE TREND
 TABLE 4 AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION, 2015 VS. 2020
    5.5 VALUE CHAIN ANALYSIS
 FIGURE 25 LATERAL FLOW ASSAYS MARKET: VALUE CHAIN ANALYSIS (2019)
    5.6 ECOSYSTEM MAP
 FIGURE 26 ECOSYSTEM: LATERAL FLOW ASSAYS MARKET (2019)
    5.7 TECHNOLOGY ANALYSIS
           5.7.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS
           5.7.2 ADJACENT TECHNOLOGY: ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAYS)
    5.8 COVID-19 IMPACT ON THE LATERAL FLOW ASSAYS MARKET

6 INDUSTRY INSIGHTS (Page No. - 87)
    6.1 INTRODUCTION
    6.2 INDUSTRY TRENDS
           6.2.1 INTEGRATION OF MICROFLUIDIC TECHNOLOGY  IN LATERAL FLOW ASSAYS
           6.2.2 DEMAND FOR QUANTITATIVE RESULTS
   TABLE 5 MANUFACTURERS AND MODELS OF OPTICAL DETECTORS FOR RECORDING IMMUNOCHROMATOGRAPHY RESULTS
   TABLE 6 EXAMPLES OF SMARTPHONE/MOBILE PHONE-BASED QUANTITATIVE LATERAL FLOW ASSAYS AND THEIR TARGET ANALYTES
           6.2.3 RISING DEMAND FOR MULTIPLEXED LATERAL FLOW BIOSENSORS
           6.2.4 NANOPARTICLE-BASED LATERAL FLOW ASSAYS
    6.3 REGULATORY ANALYSIS
 TABLE 7 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION
           6.3.1 NORTH AMERICA
           6.3.2 EUROPE
           6.3.3 ASIA
                    6.3.3.1 India
                    6.3.3.2 China
                    6.3.3.3 Japan
    6.4 COMPONENT ANALYSIS FOR LATERAL FLOW ASSAY KITS
           6.4.1 MEMBRANES
                    6.4.1.1 Nitrocellulose membranes
                    6.4.1.2 Other membranes
           6.4.2 PADS
                    6.4.2.1 Conjugate pads
                    6.4.2.2 Absorbent pads

7 LATERAL FLOW ASSAYS MARKET, BY PRODUCT (Page No. - 95)
    7.1 INTRODUCTION
 TABLE 8 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    7.2 KITS & REAGENTS
           7.2.1 INCREASING DEMAND FOR POC TESTING IS DRIVING THE DEMAND FOR KITS & REAGENTS IN THE LATERAL FLOW ASSAYS MARKET
   TABLE 9 LATERAL FLOW KITS & REAGENTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    7.3 LATERAL FLOW READERS
 TABLE 10 EXAMPLES OF LATERAL FLOW READERS AVAILABLE IN THE MARKET
 TABLE 11 LATERAL FLOW READERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
 TABLE 12 LATERAL FLOW READERS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
           7.3.1 DIGITAL/HANDHELD READERS
                    7.3.1.1 Technological advancements and high accuracy are the major factors driving the growth of the digital/handheld readers market
       TABLE 13 DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY COUNTRY,  2018-2025 (USD MILLION)
           7.3.2 BENCHTOP READERS
                    7.3.2.1 Lower diagnosis cost per patient is driving the benchtop readers market
       TABLE 14 BENCHTOP LATERAL FLOW READERS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
           7.3.3 MOBILE/SMARTPHONE READERS
                    7.3.3.1 Low cost, convenience, and user-friendliness are major factors driving the growth of the mobile/smartphone readers market

8 LATERAL FLOW ASSAYS MARKET, BY APPLICATION (Page No. - 102)
    8.1 INTRODUCTION
 TABLE 15 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    8.2 CLINICAL TESTING
 TABLE 16 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE,  2018-2025 (USD MILLION)
 TABLE 17 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY COUNTRY,  2018-2025 (USD MILLION)
           8.2.1 INFECTIOUS DISEASE TESTING
   TABLE 18 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018-2025 (USD MILLION)
   TABLE 19 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2018-2025 (USD MILLION)
                    8.2.1.1 Mosquito-borne diseases
    8.2.1.1.1 Increasing incidence of dengue is driving the growth of the lateral flow assays market for mosquito-borne diseases
       TABLE 20 MAJOR PRODUCTS: DENGUE TESTING
       TABLE 21 LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY,  2018-2025 (USD MILLION)
                    8.2.1.2 COVID-19
    8.2.1.2.1 The ongoing COVID-19 pandemic to drive the demand for rapid lateral flow tests
       TABLE 22 COVID-19 (ANTIGEN AND ANTIBODY) LATERAL FLOW ASSAY TESTS (2020)
       TABLE 23 LATERAL FLOW ASSAYS MARKET FOR COVID-19, BY COUNTRY,  2018-2025 (USD MILLION)
                    8.2.1.3 Influenza
    8.2.1.3.1 Growing prevalence of influenza globally is expected to boost the growth of the influenza testing market
       TABLE 24 LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY,  2018-2025 (USD MILLION)
                    8.2.1.4 Sexually transmitted infections
       TABLE 25 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE,  2018-2025 (USD MILLION)
       TABLE 26 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2018-2025 (USD MILLION)
    8.2.1.4.1 HIV
      8.2.1.4.1.1 Growing awareness about HIV POC testing is one of the major factors driving market growth
           FIGURE 27 PATIENTS TREATED FOR HIV GLOBALLY, 2005-2019
           TABLE 27 LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2018-2025 (USD MILLION)
    8.2.1.4.2 HPV
      8.2.1.4.2.1 Rising adoption of HPV testing to drive the market during the forecast period
           TABLE 28 LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2018-2025 (USD MILLION)
    8.2.1.4.3 Chlamydia
      8.2.1.4.3.1 Growing incidence of chlamydia and rising awareness among patients is driving the growth of this segment
           TABLE 29 LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2018-2025
    8.2.1.4.4 Gonorrhea
      8.2.1.4.4.1 Rising incidence of gonorrhea globally and increased funding for R&D to drive the lateral flow assays market during the forecast period
           TABLE 30 LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY,  2018-2025 (USD MILLION)
    8.2.1.4.5 Syphilis
      8.2.1.4.5.1 Growing adoption of novel technologies supporting the growth of the lateral flow assays market for syphilis testing
           TABLE 31 NUMBER OF CASES OF SYPHILIS, BY COUNTRY, 2011-2018
           TABLE 32 LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY,  2018-2025 (USD MILLION)
    8.2.1.4.6 Other sexually transmitted infections
       TABLE 33 LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS,  BY COUNTRY, 2018-2025 (USD MILLION)
                    8.2.1.5 Hepatitis
    8.2.1.5.1 Nucleic acid hybridization-based lateral flow assays hold great potential in the hepatitis testing market
       TABLE 34 LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY,  2018-2025 (USD MILLION)
                    8.2.1.6 Tuberculosis
    8.2.1.6.1 Rising prevalence of the disease and a growing focus on early diagnosis and treatment of tuberculosis is expected to drive this market
       TABLE 35 LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY,  2018-2025 (USD MILLION)
                    8.2.1.7 Other infectious diseases
       TABLE 36 LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2018-2025 (USD MILLION)
           8.2.2 CARDIAC MARKER TESTING
   TABLE 37 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE,  2018-2025 (USD MILLION)
   TABLE 38 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY,  2018-2025 (USD MILLION)
                    8.2.2.1 Troponin I and T testing
    8.2.2.1.1 Introduction of high-sensitivity troponin assays to drive this market during the forecast period
       TABLE 39 LATERAL FLOW ASSAYS MARKET FOR TROPONIN I AND T TESTING, BY COUNTRY,  2018-2025 (USD MILLION)
                    8.2.2.2 CK-MB testing
    8.2.2.2.1 Growing applications of lateral flow tests in acute myocardial injuries to drive this market
       TABLE 40 LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY,  2018-2025 (USD MILLION)
                    8.2.2.3 BNP and NT-proBNP testing
    8.2.2.3.1 Increasing demand for cardiac biomarker tests to detect heart stress and damage to drive growth in this market
       TABLE 41 LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY,  2018-2025 (USD MILLION)
                    8.2.2.4 Myoglobin testing
    8.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict the growth of the routine myoglobin testing market
       TABLE 42 LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY,  2018-2025 (USD MILLION)
                    8.2.2.5 D-Dimer testing
    8.2.2.5.1 Rising incidence of cardiovascular diseases globally is expected to drive the market for D-dimer tests
       TABLE 43 LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY,  2018-2025 (USD MILLION)
                    8.2.2.6 Other cardiac markers
       TABLE 44 LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTS, BY COUNTRY, 2018-2025 (USD MILLION)
           8.2.3 PREGNANCY & FERTILITY TESTING
   TABLE 45 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE,  2018-2025 (USD MILLION)
   TABLE 46 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2018-2025 (USD MILLION)
                    8.2.3.1 Pregnancy testing
    8.2.3.1.1 Pregnancy testing is among the most common application areas for lateral flow assays, registering slower growth during the forecast period
       TABLE 47 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY,  2018-2025 (USD MILLION)
                    8.2.3.2 Fertility testing
    8.2.3.2.1 Rising infertility rates across the globe driving the demand for POC fertility testing kits
       TABLE 48 LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY,  2018-2025 (USD MILLION)
           8.2.4 CHOLESTEROL TESTING/LIPID PROFILES
                    8.2.4.1 Growing prevalence of obesity and CVD is the key factor driving market growth
       TABLE 49 LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILES,  BY COUNTRY, 2018-2025 (USD MILLION)
           8.2.5 DRUGS-OF-ABUSE TESTING
                    8.2.5.1 Technological advancements and growing focus on workplace drug testing are driving market growth
       TABLE 50 LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY,  2018-2025 (USD MILLION)
           8.2.6 OTHER CLINICAL TESTS
   TABLE 51 LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY,  2018-2025 (USD MILLION)
    8.3 VETERINARY DIAGNOSTICS
           8.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH
   TABLE 52 LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY,  2018-2025 (USD MILLION)
    8.4 FOOD SAFETY & ENVIRONMENT TESTING
           8.4.1 HIGH SENSITIVITY AND EASE OF USE ARE DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING
   TABLE 53 LATERAL FLOW ASSAYS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING,  BY COUNTRY, 2018-2025 (USD MILLION)
    8.5 DRUG DEVELOPMENT & QUALITY TESTING
           8.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE IS DRIVING THE GROWTH OF THIS MARKET
   TABLE 54 LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING,  BY COUNTRY, 2018-2025 (USD MILLION)
    8.6 COVID-19 IMPACT ON THE LATERAL FLOW ASSAY APPLICATION MARKET

9 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE (Page No. - 144)
    9.1 INTRODUCTION
 TABLE 55 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
    9.2 SANDWICH ASSAYS
           9.2.1 WIDE APPLICATIONS OF SANDWICH ASSAYS IN CLINICAL TESTING CONTRIBUTING TO THE LARGEST SHARE OF THIS SEGMENT
   TABLE 56 LATERAL FLOW SANDWICH ASSAYS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    9.3 COMPETITIVE ASSAYS
           9.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER GROWTH
   TABLE 57 LATERAL FLOW COMPETITIVE ASSAYS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    9.4 MULTIPLEX DETECTION ASSAYS
           9.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE THE GROWTH OF THIS MARKET
   TABLE 58 LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET, BY COUNTRY,  2018-2025 (USD MILLION)

10 CLINICAL TESTING LATERAL FLOW ASSAYS MARKET,  BY SAMPLE TYPE (Page No. - 149)
    10.1 INTRODUCTION
  TABLE 59 CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018-2025 (USD MILLION)
    10.2 BLOOD SAMPLES
           10.2.1 INCREASING USE OF BLOOD SAMPLES FOR INFECTIOUS DISEASE TESTING TO DRIVE THE GROWTH OF THIS SEGMENT
    TABLE 60 CLINICAL TESTING LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2018-2025 (USD MILLION)
    10.3 URINE SAMPLES
           10.3.1 GROWING USE OF URINE SAMPLES FOR PREGNANCY TESTING AND DRUGS-OF-ABUSE TESTING TO DRIVE THE GROWTH OF THIS MARKET
    TABLE 61 CLINICAL TESTING LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY,  2018-2025 (USD MILLION)
    10.4 SALIVA SAMPLES
           10.4.1 EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES ARE THE KEY FACTORS DRIVING MARKET GROWTH
    TABLE 62 CLINICAL TESTING LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY,  2018-2025 (USD MILLION)
    10.5 OTHER SAMPLES
  TABLE 63 CLINICAL TESTING LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2018-2025 (USD MILLION)

11 LATERAL FLOW ASSAYS MARKET, BY END USER (Page No. - 155)
    11.1 INTRODUCTION
  TABLE 64 LATERAL FLOW ASSAYS MARKET, BY END USER, 2018-2025 (USD MILLION)
    11.2 HOSPITALS & CLINICS
           11.2.1 INCREASING USE OF POC TESTS DRIVING THE ADOPTION OF LATERAL FLOW ASSAYS AMONG HOSPITALS & CLINICS
    TABLE 65 LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY,  2018-2025 (USD MILLION)
    11.3 DIAGNOSTIC LABORATORIES
           11.3.1 LABORATORY TESTING IS LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING-A KEY FACTOR DRIVING MARKET GROWTH
    TABLE 66 LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY,  2018-2025 (USD MILLION)
    11.4 HOME CARE SETTINGS
           11.4.1 GROWING ACCEPTANCE OF REMOTE MONITORING DRIVING THE GROWTH OF THE LATERAL FLOW ASSAYS MARKET FOR HOME CARE
    TABLE 67 LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY,  2018-2025 (USD MILLION)
    11.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
           11.5.1 INCREASING FOCUS ON PRODUCT SAFETY TO DRIVE THE USE OF LATERAL FLOW ASSAYS AMONG PHARMACEUTICAL & BIOTECH COMPANIES
    TABLE 68 LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
    11.6 OTHER END USERS
  TABLE 69 LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY,  2018-2025 (USD MILLION)

12 LATERAL FLOW ASSAYS MARKET, BY REGION (Page No. - 162)
    12.1 INTRODUCTION
  FIGURE 28 US TO DOMINATE THE LATERAL FLOW ASSAYS MARKET DURING THE FORECAST PERIOD
  TABLE 70 LATERAL FLOW ASSAYS MARKET, BY REGION, 2018-2025 (USD MILLION)
    12.2 NORTH AMERICA
  TABLE 71 NORTH AMERICA: MACROECONOMIC INDICATORS
  FIGURE 29 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT
  TABLE 72 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY,  2018-2025 (USD MILLION)
  TABLE 73 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2018-2025 (USD MILLION)
  TABLE 74 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE,  2018-2025 (USD MILLION)
  TABLE 75 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
  TABLE 76 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  TABLE 77 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018-2025 (USD MILLION)
  TABLE 78 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018-2025 (USD MILLION)
  TABLE 79 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,  BY TYPE, 2018-2025 (USD MILLION)
  TABLE 80 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018-2025 (USD MILLION)
  TABLE 81 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
  TABLE 82 NORTH AMERICA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018-2025 (USD MILLION)
  TABLE 83 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER,  2018-2025 (USD MILLION)
           12.2.1 US
                    12.2.1.1 The US accounts for the largest share of the lateral flow assays market in North America
        TABLE 84 US: MACROECONOMIC INDICATORS
        TABLE 85 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
        TABLE 86 US: LATERAL FLOW READERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 87 US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
        TABLE 88 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 89 US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018-2025 (USD MILLION)
        TABLE 90 US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 91 US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE,  2018-2025 (USD MILLION)
        TABLE 92 US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 93 US: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
        TABLE 94 US: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018-2025 (USD MILLION)
        TABLE 95 US: LATERAL FLOW ASSAYS MARKET, BY END USER,2018-2025 USD MILLION)
           12.2.2 CANADA
                    12.2.2.1 Availability of research funding and implementation of favorable government initiatives are driving the market in Canada
        TABLE 96 CANADA: MACROECONOMIC INDICATORS
        TABLE 97 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
        TABLE 98 CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 99 CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
        TABLE 100 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,  BY TYPE, 2018-2025 (USD MILLION)
        TABLE 101 CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,  BY DISEASE TYPE, 2018-2025 (USD MILLION)
        TABLE 102 CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2020-2025 (USD MILLION)
        TABLE 103 CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 104 CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,  BY TYPE, 2018-2025 (USD MILLION)
        TABLE 105 CANADA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
        TABLE 106 CANADA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018-2025 (USD MILLION)
        TABLE 107 CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2018-2025 (USD MILLION)
    12.3 COVID-19 IMPACT ON THE LATERAL FLOW ASSAYS MARKET IN NORTH AMERICA
    12.4 EUROPE
  TABLE 108 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  TABLE 109 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  TABLE 110 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  TABLE 111 EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  TABLE 112 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,  BY TYPE, 2018-2025 (USD MILLION)
  TABLE 113 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,  BY DISEASE TYPE, 2018-2025 (USD MILLION)
  TABLE 114 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018-2025 (USD MILLION)
  TABLE 115 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018-2025 (USD MILLION)
  TABLE 116 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,  BY TYPE, 2018-2025 (USD MILLION)
  TABLE 117 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
  TABLE 118 EUROPE: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018-2025 (USD MILLION)
  TABLE 119 EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2018-2025 (USD MILLION)
           12.4.1 GERMANY
                    12.4.1.1 Growing number of the POC diagnostics centers to drive the demand for lateral flow assays in Germany
        TABLE 120 GERMANY: MACROECONOMIC INDICATORS
        TABLE 121 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
        TABLE 122 GERMANY: LATERAL FLOW READERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 123 GERMANY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
        TABLE 124 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,  BY TYPE, 2018-2025 (USD MILLION)
        TABLE 125 GERMANY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,  BY DISEASE TYPE, 2018-2025 (USD MILLION)
        TABLE 126 GERMANY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 127 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 128 GERMANY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,  BY TYPE, 2018-2025 (USD MILLION)
        TABLE 129 GERMANY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
        TABLE 130 GERMANY: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018-2025 (USD MILLION)
        TABLE 131 GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2018-2025 (USD MILLION)
           12.4.2 FRANCE
                    12.4.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France
        TABLE 132 FRANCE: MACROECONOMIC INDICATORS
        TABLE 133 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
        TABLE 134 FRANCE: LATERAL FLOW READERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 135 FRANCE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
        TABLE 136 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,  BY TYPE, 2018-2025 (USD MILLION)
        TABLE 137 FRANCE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,  BY DISEASE TYPE, 2018-2025 (USD MILLION)
        TABLE 138 FRANCE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018-2025 (USD MILLION)
        TABLE 139 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 140 FRANCE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,  BY TYPE, 2018-2025 (USD MILLION)
        TABLE 141 FRANCE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
        TABLE 142 FRANCE: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018-2025 (USD MILLION)
        TABLE 143 FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2018-2025 (USD MILLION)
           12.4.3 UK
                    12.4.3.1 Increasing incidence of chronic diseases and rising prevalence of obesity propelling the market growth in the UK
        TABLE 144 UK: MACROECONOMIC INDICATORS
        TABLE 145 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
        TABLE 146 UK: LATERAL FLOW READERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 147 UK: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
        TABLE 148 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 149 UK: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018-2025 (USD MILLION)
        TABLE 150 UK: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 151 UK: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE,  2018-2025 (USD MILLION)
        TABLE 152 UK: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 153 UK: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
        TABLE 154 UK: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018-2025 (USD MILLION)
        TABLE 155 UK: LATERAL FLOW ASSAYS MARKET, BY END USER, 2018-2025 (USD MILLION)
           12.4.4 ITALY
                    12.4.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country
        TABLE 156 ITALY: MACROECONOMIC INDICATORS
        TABLE 157 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
        TABLE 158 ITALY: LATERAL FLOW READERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 159 ITALY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
        TABLE 160 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 161 ITALY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018-2025 (USD MILLION)
        TABLE 162 ITALY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018-2025 (USD MILLION)
        TABLE 163 ITALY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE,  2018-2025 (USD MILLION)
        TABLE 164 ITALY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 165 ITALY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
        TABLE 166 ITALY: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018-2025 (USD MILLION)
        TABLE 167 ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2018-2025 (USD MILLION)
           12.4.5 SPAIN
                    12.4.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth
        TABLE 168 SPAIN: MACROECONOMIC INDICATORS
        TABLE 169 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
        TABLE 170 SPAIN: LATERAL FLOW READERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 171 SPAIN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
        TABLE 172 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 173 SPAIN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018-2025 (USD MILLION)
        TABLE 174 SPAIN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018-2025 (USD MILLION)
        TABLE 175 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE,  2018-2025 (USD MILLION)
        TABLE 176 SPAIN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 177 SPAIN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
        TABLE 178 SPAIN: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018-2025 (USD MILLION)
        TABLE 179 SPAIN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2018-2025 (USD MILLION)
           12.4.6 REST OF EUROPE
    TABLE 180 ROE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    TABLE 181 ROE: LATERAL FLOW READERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    TABLE 182 ROE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    TABLE 183 ROE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
    TABLE 184 ROE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018-2025 (USD MILLION)
    TABLE 185 ROE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018-2025 (USD MILLION)
    TABLE 186 ROE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE,  2018-2025 (USD MILLION)
    TABLE 187 ROE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018-2025 (USD MILLION)
    TABLE 188 ROE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
    TABLE 189 ROE: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018-2025 (USD MILLION)
    TABLE 190 ROE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2018-2025 (USD MILLION)
    12.5 COVID-19 IMPACT ON THE LATERAL FLOW ASSAYS MARKET IN EUROPE
    12.6 ASIA PACIFIC
  FIGURE 30 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET SNAPSHOT
  TABLE 191 APAC: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  TABLE 192 APAC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  TABLE 193 APAC: LATERAL FLOW READERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  TABLE 194 APAC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  TABLE 195 APAC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  TABLE 196 APAC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018-2025 (USD MILLION)
  TABLE 197 APAC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018-2025 (USD MILLION)
  TABLE 198 APAC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE,  2018-2025 (USD MILLION)
  TABLE 199 APAC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018-2025 (USD MILLION)
  TABLE 200 APAC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
  TABLE 201 APAC: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018-2025 (USD MILLION)
  TABLE 202 APAC: LATERAL FLOW ASSAYS MARKET, BY END USER, 2018-2025 (USD MILLION)
           12.6.1 CHINA
                    12.6.1.1 Growing adoption of lateral flow assays in veterinary diagnostics and drug development is expected to drive the market growth in China
        TABLE 203 CHINA: MACROECONOMIC INDICATORS
        TABLE 204 CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
        TABLE 205 CHINA: LATERAL FLOW READERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 206 CHINA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
        TABLE 207 CHINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 208 CHINA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018-2025 (USD MILLION)
        TABLE 209 CHINA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018-2025 (USD MILLION)
        TABLE 210 CHINA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018-2025 (USD MILLION) 224
        TABLE 211 CHINA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 212 CHINA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
        TABLE 213 CHINA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018-2025 (USD MILLION)
        TABLE 214 CHINA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2018-2025 (USD MILLION)
           12.6.2 JAPAN
                    12.6.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assays market in Japan
        TABLE 215 JAPAN: MACROECONOMIC INDICATORS
        TABLE 216 JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
        TABLE 217 JAPAN: LATERAL FLOW READERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 218 JAPAN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
        TABLE 219 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 220 JAPAN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018-2025 (USD MILLION)
        TABLE 221 JAPAN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018-2025 (USD MILLION)
        TABLE 222 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 223 JAPAN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 224 JAPAN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
        TABLE 225 JAPAN: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018-2025 (USD MILLION)
        TABLE 226 JAPAN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2018-2025 (USD MILLION)
           12.6.3 INDIA
                    12.6.3.1 Increasing prevalence of chronic disorders, growing healthcare concerns, and rising income levels to propel the growth of this market
        TABLE 227 INDIA: MACROECONOMIC INDICATORS
        TABLE 228 INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
        TABLE 229 INDIA: LATERAL FLOW READERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 230 INDIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
        TABLE 231 INDIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 232 INDIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018-2025 (USD MILLION)
        TABLE 233 INDIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018-2025 (USD MILLION)
        TABLE 234 INDIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE,  2018-2025 (USD MILLION)
        TABLE 235 INDIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 236 INDIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
        TABLE 237 INDIA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018-2025 (USD MILLION)
        TABLE 238 INDIA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2018-2025 (USD MILLION)
           12.6.4 AUSTRALIA
                    12.6.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assays market
        TABLE 239 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
        TABLE 240 AUSTRALIA: LATERAL FLOW READERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 241 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
        TABLE 242 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,  BY TYPE, 2018-2025 (USD MILLION)
        TABLE 243 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,  BY DISEASE TYPE, 2018-2025 (USD MILLION)
        TABLE 244 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 245 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 246 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,  BY TYPE, 2018-2025 (USD MILLION)
        TABLE 247 AUSTRALIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION) 239
        TABLE 248 AUSTRALIA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018-2025 (USD MILLION)
        TABLE 249 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2018-2025 (USD MILLION)
           12.6.5 REST OF ASIA PACIFIC
    TABLE 250 ROAPAC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    TABLE 251 ROAPAC: LATERAL FLOW READERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    TABLE 252 ROAPAC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    TABLE 253 ROAPAC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,  BY TYPE, 2018-2025 (USD MILLION)
    TABLE 254 ROAPAC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,  BY DISEASE TYPE, 2018-2025 (USD MILLION)
    TABLE 255 ROAPAC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018-2025 (USD MILLION)
    TABLE 256 ROAPAC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018-2025 (USD MILLION)
    TABLE 257 ROAPAC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,  BY TYPE, 2018-2025 (USD MILLION)
    TABLE 258 ROAPAC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
    TABLE 259 ROAPAC: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018-2025 (USD MILLION)
    TABLE 260 ROAPAC: LATERAL FLOW ASSAYS MARKET, BY END USER, 2018-2025 (USD MILLION)
    12.7 COVID-19 IMPACT ON THE LATERAL FLOW ASSAYS MARKET IN THE ASIA PACIFIC
    12.8 LATIN AMERICA
  TABLE 261 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY,  2018-2025 (USD MILLION)
  TABLE 262 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2018-2025 (USD MILLION)
  TABLE 263 LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  TABLE 264 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,  2018-2025 (USD MILLION)
  TABLE 265 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
  TABLE 266 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,  BY DISEASE TYPE, 2018-2025 (USD MILLION)
  TABLE 267 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018-2025 (USD MILLION)
  TABLE 268 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,  BY TYPE, 2018-2025 (USD MILLION)
  TABLE 269 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018-2025 (USD MILLION)
  TABLE 270 LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
  TABLE 271 LATIN AMERICA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018-2025 (USD MILLION)
  TABLE 272 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER,  2018-2025 (USD MILLION) 249
           12.8.1 BRAZIL
                    12.8.1.1 High private healthcare expenditure and increasing geriatric population driving the growth of the lateral flow assays market in the country
        TABLE 273 BRAZIL: MACROECONOMIC INDICATORS
        TABLE 274 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
        TABLE 275 BRAZIL: LATERAL FLOW READERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 276 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
        TABLE 277 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 278 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018-2025 (USD MILLION)
        TABLE 279 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018-2025 (USD MILLION)
        TABLE 280 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE,  2018-2025 (USD MILLION)
        TABLE 281 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 282 BRAZIL: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
        TABLE 283 BRAZIL: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018-2025 (USD MILLION)
        TABLE 284 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY END USER, 2018-2025 (USD MILLION)
           12.8.2 MEXICO
                    12.8.2.1 High prevalence of obesity and related chronic diseases to boost the growth of the lateral flow assays market in the forecast period
        TABLE 285 MEXICO: MACROECONOMIC INDICATORS
        TABLE 286 MEXICO: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
        TABLE 287 MEXICO: LATERAL FLOW READERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
        TABLE 288 MEXICO: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
        TABLE 289 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,  BY TYPE, 2018-2025 (USD MILLION)
        TABLE 290 MEXICO: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,  BY DISEASE TYPE, 2018-2025 (USD MILLION)
        TABLE 291 MEXICO: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018-2025 (USD MILLION)
        TABLE 292 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE,  2018-2025 (USD MILLION)
        TABLE 293 MEXICO: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,  BY TYPE, 2018-2025 (USD MILLION)
        TABLE 294 MEXICO: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
        TABLE 295 MEXICO: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018-2025 (USD MILLION)
        TABLE 296 MEXICO: LATERAL FLOW ASSAYS MARKET, BY END USER, 2018-2025 (USD MILLION)
           12.8.3 REST OF LATIN AMERICA
    TABLE 297 ROLATAM: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    TABLE 298 ROLATAM: LATERAL FLOW READERS MARKET, BY TYPE,  2018-2025 (USD MILLION)
    TABLE 299 ROLATAM: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    TABLE 300 ROLATAM: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,  BY TYPE, 2018-2025 (USD MILLION)
    TABLE 301 ROLATAM: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,  BY DISEASE TYPE, 2018-2025 (USD MILLION)
    TABLE 302 ROLATAM: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018-2025 (USD MILLION)
    TABLE 303 ROLATAM: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE,  2018-2025 (USD MILLION)
    TABLE 304 ROLATAM: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,  BY TYPE, 2018-2025 (USD MILLION)
    TABLE 305 ROLATAM: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018-2025 (USD MILLION)
    TABLE 306 ROLATAM: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018-2025 (USD MILLION)
    TABLE 307 ROLATAM: LATERAL FLOW ASSAYS MARKET, BY END USER, 2018-2025 (USD MILLION)
    12.9 COVID-19 IMPACT ON THE LATERAL FLOW ASSAYS MARKET IN LATIN AMERICA
    12.1 MIDDLE EAST & AFRICA
           12.10.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANSION OF HEALTHCARE SERVICES IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAYS
     TABLE 308 AFRICA: MACROECONOMIC INDICATORS
     TABLE 309 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2018-2025 (USD MILLION)
     TABLE 310 MIDDLE EAST & AFRICA: LATERAL FLOW READERS MARKET, BY TYPE,  2018-2025 (USD MILLION)
     TABLE 311 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 20180-2025 (USD MILLION)
     TABLE 312 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
     TABLE 313 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018-2025 (USD MILLION)
     TABLE 314 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018-2025 (USD MILLION)
     TABLE 315 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020-2025 (USD MILLION)
     TABLE 316 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018-2025 (USD MILLION)
     TABLE 317 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY KITS & REAGENTS MARKET,  BY TECHNIQUE, 2018-2025 (USD MILLION)
     TABLE 318 MIDDLE EAST & AFRICA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018-2025 (USD MILLION)
     TABLE 319 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY END USER,  2018-2025 (USD MILLION)
    12.11 COVID-19 IMPACT ON THE LATERAL FLOW ASSAYS MARKET IN THE MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE (Page No. - 270)
    13.1 INTRODUCTION
  FIGURE 31 KEY DEVELOPMENTS IN THE GLOBAL LATERAL FLOW ASSAYS MARKET,  2018-2020
  FIGURE 32 MARKET EVALUATION FRAMEWORK: PRODUCT LAUNCHES DOMINATED THE MARKET BETWEEN 2018 TO 2020
    13.2 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
  FIGURE 33 TOP MARKET PLAYERS DOMINATE THE LATERAL FLOW ASSAYS MARKET
    13.3 PRODUCT BENCHMARKING
  FIGURE 34 PRODUCT PORTFOLIO ANALYSIS: LATERAL FLOW ASSAYS MARKET (2019)
    13.4 GEOGRAPHICAL ASSESSMENT OF MAJOR PLAYERS IN THE LATERAL FLOW ASSAYS MARKET
  FIGURE 35 GEOGRAPHIC REVENUE MIX: LATERAL FLOW ASSAYS MARKET (2019)
    13.5 COMPETITIVE ASSESSMENT OF THE R&D EXPENDITURE
  FIGURE 36 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAYS MARKET, 2017 VS. 2019
    13.6 COMPETITIVE SITUATIONS AND TRENDS
           13.6.1 PRODUCT LAUNCHES
                  TABLE 320 PRODUCT LAUNCHES
           13.6.2 EXPANSIONS
                  TABLE 321 EXPANSIONS
           13.6.3 ACQUISITIONS
                  TABLE 322 ACQUISITIONS
           13.6.4 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
                  TABLE 323 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS

14 COMPANY EVALUATION MATRIX AND COMPANY PROFILES (Page No. - 280)
    14.1 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY
    14.2 LATERAL FLOW ASSAYS MARKET SHARE (2019)
  FIGURE 37 LATERAL FLOW ASSAYS MARKET SHARE, BY KEY PLAYER (2019)
    14.3 COMPETITIVE LEADERSHIP MAPPING
           14.3.1 STARS
           14.3.2 EMERGING LEADERS
           14.3.3 PERVASIVE PLAYERS
           14.3.4 PARTICIPANTS
                  FIGURE 38 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX, 2019
    14.4 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2019)
           14.4.1 PROGRESSIVE COMPANIES
           14.4.2 DYNAMIC COMPANIES
           14.4.3 STARTING BLOCKS
           14.4.4 RESPONSIVE COMPANIES
                  FIGURE 39 LATERAL FLOW ASSAYS MARKET: START-UP COMPANY EVALUATION MATRIX, 2019
    14.5 COMPANY PROFILES
  (Business overview, Products offered, Recent developments, SWOT analysis and MNM view)*
           14.5.1 ABBOTT LABORATORIES
                  FIGURE 40 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
           14.5.2 F. HOFFMANN-LA ROCHE AG
                  FIGURE 41 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2019)
           14.5.3 DANAHER CORPORATION
                  FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
           14.5.4 SIEMENS AG
           14.5.5 BECTON, DICKINSON AND COMPANY
           14.5.6 BIOMÉRIEUX SA
           14.5.7 BIO-RAD LABORATORIES, INC.
           14.5.8 THERMO FISHER SCIENTIFIC INC.
           14.5.9 QIAGEN N.V.
           14.5.10 PERKINELMER INC.
                   FIGURE 49 PERKINELMER INC.: COMPANY SNAPSHOT (2019)
           14.5.11 HOLOGIC INC.
                   FIGURE 50 HOLOGIC, INC.: COMPANY SNAPSHOT (2019)
           14.5.12 QUIDEL CORPORATION
                   FIGURE 51 QUIDEL CORPORATION: COMPANY SNAPSHOT (2019)
           14.5.13 MERCK KGAA
                   FIGURE 52 MERCK KGAA: COMPANY SNAPSHOT (2019)
           14.5.14 ABCAM PLC
                   FIGURE 53 ABCAM PLC: COMPANY SNAPSHOT (2019)
           14.5.15 SURMODICS IVD
                   FIGURE 54 SURMODICS IVD: COMPANY SNAPSHOT (2019)
           14.5.16 CHEMBIO DIAGNOSTIC SYSTEMS, INC.
                   FIGURE 55 CHEMBIO DIAGNOSTIC SYSTEMS, INC.: COMPANY SNAPSHOT (2019)
           14.5.17 ORASURE TECHNOLOGIES
                   FIGURE 56 ORASURE TECHNOLOGIES: COMPANY SNAPSHOT (2019)
           14.5.18 DCN DIAGNOSTICS
           14.5.19 POLYSCIENCES, INC.
           14.5.20 ABINGDON HEALTH
                  

*Details on Business overview, Products offered, Recent developments, SWOT analysis and MNM viewmight not be captured in case of unlisted companies.

15 APPENDIX (Page No. - 337)
    15.1 INSIGHTS FROM INDUSTRY EXPERTS
    15.2 DISCUSSION GUIDE
    15.3 KNOWLEDGE STORE: MARKETSANDMARKETS'  SUBSCRIPTION PORTAL
    15.4 AVAILABLE CUSTOMIZATIONS
    15.5 RELATED REPORTS
    15.6 AUTHOR DETAILS

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies. 

Secondary Research

Secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Business, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the lateral flow assaymarket. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research. 

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The lateral flow assay market comprises several stakeholders such as raw material suppliers, processors, end-product manufacturers, distributors, and regulatory organizations in the supply chain. The demand side of this market is characterized by the development of the hospitals & clinics, diagnostic laboratories, home care, food & beverage, pharmaceutical, nutraceutical & biotechnology companies, and environment testing industry. The supply side is characterized by advancements in technology and diverse application industries. Various primary sources from both, the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics. 

A breakdown of the primary respondents is provided below: 

Lateral Flow Assays Market Size

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by product, by application, by technique, by sample type, by end user and by region). 

Data Triangulation

After arriving at the market size, the total lateral flow assaymarket was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable. 

Objectives of the Study

  • To define, describe, analyze, and forecast the size of the lateral flow assay market on the basis ofproduct, application, technique, sample type, end user and region.
  • To provide detailed information on the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To forecast the size of the market segments with respect to North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
  • To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies2
  • To track and analyze competitive developments such as product launches, expansions, partnerships, agreements, collaborations, acquisitions and other developments in the market
  • To benchmark players within the lateral flow assay market using the Competitive Leadership Mapping framework which analyzes market players on various parameters within the broad categories of business and product strategy 

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players 

Geographic Analysis

  • Furtherbreakdown of the Rest of Asia Pacific lateral flow assaymarket into South Korea, New Zealand, and other countries.
COVID-19

Get in-depth analysis of the COVID-19 impact on the Lateral Flow Assays Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Lateral Flow Assays Market

Request For Special Pricing
Report Code
MD 4158
Published ON
Nov, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Lateral Flow Assays Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home